NCT04856046View on ClinicalTrials.gov

Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

November 6, 2021

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Resectable Hepatocellular Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood sample

OTHER

Electronic Health Record Review

Review of medical records

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04856046 - Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer | Biotech Hunter | Biotech Hunter